[go: up one dir, main page]

AU2002213882A1 - Attenuated hiv strains and use thereof - Google Patents

Attenuated hiv strains and use thereof

Info

Publication number
AU2002213882A1
AU2002213882A1 AU2002213882A AU1388202A AU2002213882A1 AU 2002213882 A1 AU2002213882 A1 AU 2002213882A1 AU 2002213882 A AU2002213882 A AU 2002213882A AU 1388202 A AU1388202 A AU 1388202A AU 2002213882 A1 AU2002213882 A1 AU 2002213882A1
Authority
AU
Australia
Prior art keywords
hiv strains
attenuated hiv
attenuated
strains
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213882A
Inventor
Marion Cornelissen
Jaap Goudsmit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux BV
Original Assignee
Organon Teknika BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Teknika BV filed Critical Organon Teknika BV
Publication of AU2002213882A1 publication Critical patent/AU2002213882A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002213882A 2000-09-08 2001-09-05 Attenuated hiv strains and use thereof Abandoned AU2002213882A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00203116.9 2000-09-08
EP00203116 2000-09-08
PCT/EP2001/010244 WO2002020571A2 (en) 2000-09-08 2001-09-05 Attenuated hiv strains and use thereof

Publications (1)

Publication Number Publication Date
AU2002213882A1 true AU2002213882A1 (en) 2002-03-22

Family

ID=8171998

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213882A Abandoned AU2002213882A1 (en) 2000-09-08 2001-09-05 Attenuated hiv strains and use thereof

Country Status (3)

Country Link
EP (1) EP1315799A2 (en)
AU (1) AU2002213882A1 (en)
WO (1) WO2002020571A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270464B1 (en) 1998-06-22 2001-08-07 Artemis Medical, Inc. Biopsy localization method and device
AU2001232485A1 (en) 2000-01-13 2001-07-24 Amsterdam Support Diagnostics B.V. A universal nucleic acid amplification system for nucleic acids in a sample
US8206913B1 (en) 2003-03-07 2012-06-26 Rubicon Genomics, Inc. Amplification and analysis of whole genome and whole transcriptome libraries generated by a DNA polymerization process
US7718403B2 (en) 2003-03-07 2010-05-18 Rubicon Genomics, Inc. Amplification and analysis of whole genome and whole transcriptome libraries generated by a DNA polymerization process
EP2290106B1 (en) 2004-03-08 2018-01-03 Rubicon Genomics, Inc. Method for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
US8409804B2 (en) 2005-08-02 2013-04-02 Rubicon Genomics, Inc. Isolation of CpG islands by thermal segregation and enzymatic selection-amplification method
WO2007018601A1 (en) 2005-08-02 2007-02-15 Rubicon Genomics, Inc. Compositions and methods for processing and amplification of dna, including using multiple enzymes in a single reaction
EP1960554B1 (en) * 2005-12-07 2011-06-08 Tibotec Pharmaceuticals Methods, plasmid vectors and primers for assessing hiv viral fitness
BR112014002134A2 (en) * 2011-08-24 2017-02-21 Grifols Therapeutics Inc polynucleotide, composition, method for determining the presence of a target nucleic acid in a sample, and kit
US10806748B2 (en) * 2015-04-24 2020-10-20 The Johns Hopkins University Compositions and methods related to characterizing proviral reservoirs
US20230122226A1 (en) * 2020-03-05 2023-04-20 Board Of Regents Of The University Of Nebraska Crispr/cas9 system for multistrain hiv-1 treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017825A1 (en) * 1993-02-05 1994-08-18 The Regents Of The University Of California Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use

Also Published As

Publication number Publication date
WO2002020571A2 (en) 2002-03-14
EP1315799A2 (en) 2003-06-04
WO2002020571A3 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2001287299A1 (en) Benzoylpyrazols and their use as herbicides
AU2002221749A1 (en) Synthetic viruses and uses thereof
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU2001261750A1 (en) Laminate and its use
AU2002213882A1 (en) Attenuated hiv strains and use thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU7458201A (en) Laminate and use thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001271732A1 (en) 25869, a human carboxylesterase and uses thereof
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU2002239395A1 (en) Hiv treatment with benzimidazoles
AU2001252627A1 (en) Polybenzasol fiber and use of the same
GB0001475D0 (en) Virus strains
AU4432001A (en) Trityl-type compounds and their use
AU2001276258A1 (en) Ceramic component and the use thereof
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2001233588A1 (en) New toralactone and its derivation and the use of decreasing blood-fat and losing weight